+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ethnicity, lipids and cardiovascular disease



Ethnicity, lipids and cardiovascular disease



Current Opinion in Lipidology 28(3): 225-230



The prevalence of cardiovascular disease differs among ethnic groups and along geographic boundaries. At present, most of the projected increase in mortality from cardiovascular disease occurs in sub-Saharan African, Chinese and Southeast Asian populations. Ethnic disparities in the prevalence of cardiovascular disease coincide with quantitative and qualitative differences in risk factors for cardiovascular disease. High plasma cholesterol is one of the most important preventable causes of ischemic heart disease. The current review summarizes recent evidence on ethnic differences in ischemic heart disease and its correlates with genetic and acquired differences in plasma lipid and lipoprotein levels. The nature of ethnic differences in plasma lipid levels, apolipoprotein L1 en lipoprotein(a) [Lp(a)] is outlined, and the effects of lipid-lowering therapy and future efforts and challenges regarding implementation are discussed. Ethnic differences in HDL-cholesterol (HDL-C), triglyceride levels and Lp(a) may impact ethnic differences in cardiovascular disease and result in higher residual risk during lipid-lowering therapy. Further efforts should be made to stimulate the use of statins in both high-income and low-income countries and study their effects in individuals with different ethnic backgrounds.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059700849

Download citation: RISBibTeXText

PMID: 28338521

DOI: 10.1097/MOL.0000000000000412


Related references

Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care 33(3): 520-525, 2010

Ethnicity and cardiovascular disease. Qjm 104(6): 467-468, 2011

Gender, ethnicity, and cardiovascular disease. Journal of Cardiovascular Nursing 20(1): 1-6; Quiz 7-8, 2005

Diabetes, cardiovascular disease, and ethnicity. Journal of the American College of Cardiology 61(17): 1787-1789, 2013

Social inequality, ethnicity and cardiovascular disease. International Journal of Epidemiology 30 Suppl 1(): S48-S52, 2002

The threat of ethnicity for cardiovascular disease risk. Journal of Hypertension 30(2): 269-270, 2012

Genetics of cardiovascular disease: Importance of sex and ethnicity. Atherosclerosis 241(1): 219-228, 2016

Inflammatory biomarkers, race/ethnicity and cardiovascular disease. Nutrition Reviews 65(Supplement s3): 0-0, 2007

Ethnicity, haemostasis and cardiovascular disease: the evidence from Africa. Central African Journal of Medicine 38(9): 385-391, 1992

Inflammatory biomarkers, race/ethnicity and cardiovascular disease. Nutrition Reviews 65(12 Pt 2): S234-S238, 2008

Apolipoprotein A-1, but not traditional lipids, predictive for recurrent cardiovascular events in patients with coronary artery disease and lipids treated to target levels. European Heart Journal 21(Abstract Supplement): 600, August-September, 2000

Ethnicity and cardiovascular disease: The Evans County heart study. American Journal of the Medical Sciences 311(3): 130-134, 1996

Pathways by which SES and ethnicity influence cardiovascular disease risk factors. Annals of the New York Academy of Sciences 896: 191-209, 2000

Ethnicity and cardiovascular disease prevention: practical clinical considerations. Current Opinion in Cardiology 23(5): 465-470, 2008

Race/Ethnicity and patient confidence to self-manage cardiovascular disease. Medical Care 46(9): 924-929, 2008